Jenkins, David J A <br/><br/>
Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial.  [electronic resource] 

 -  The American journal of clinical nutrition  May 2002 
 - 834-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9165 
<br/><br/><label>Standard No.: </label>10.1093/ajcn/75.5.834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Apolipoproteins--blood<br/>Blood Pressure--drug effects<br/>Cardiovascular Diseases--etiology<br/>Cross-Over Studies<br/>Dietary Fiber--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Approval<br/>Female<br/>Glucans--administration & dosage<br/>Health Status<br/>Humans<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Psyllium--administration & dosage<br/>Risk Assessment<br/>Risk Factors<br/>Solubility